Sepsis-Induced Tissue Hypoperfusion

Critical Care Nursing Clinics of North America

Volumn 23, Issue 1, 2011, Pages 115-125

  Jones, Alan E ^a   Puskarich, Michael A ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Emergency; Hypoperfusion; Infection; Lactate; Resuscitation; Sepsis; Septic shock

Indexed keywords

OXYGEN;

BLOOD; HEMODYNAMICS; HUMAN; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK;

HEMODYNAMICS; HUMANS; MICROCIRCULATION; OXYGEN; SEPSIS; SHOCK, SEPTIC;

EID: 79751470456     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2010.12.007     Document Type: Review

References (68)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Dombrovskiy V.Y., Martin A.A., Sunderram J., et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35:1244-1250.
3. Jones A.E., Kline J.A. Shock. Emergency medicine concepts and clinical practice 2006, Mosby, St Louis (MO). 6th edition. J.A. Marx, R.M. Walls (Eds.).
4. Watts J.A., Kline J.A. Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad Emerg Med 2003, 10:985-997.
5. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 1993, 328:1471-1477.
6. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
7. Parrillo J.E., Parker M.M., Natanson C., et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990, 113:227-242.
8. Parker M.M., Shelhamer J.H., Bacharach S.L., et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984, 100:483-490.
9. Dellinger R.P. Cardiovascular management of septic shock. Crit Care Med 2003, 31:946-955.
10. Kumar A., Haery C., Parrillo J.E. Myocardial dysfunction in septic shock. Crit Care Clin 2000, 16:251-287.
11. Zanotti Cavazzoni S.L., Dellinger R.P. Hemodynamic optimization of sepsis-induced tissue hypoperfusion. Crit Care 2006, 10(Suppl 3):S2.
12. De Backer D., Creteur J., Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104.
13. Sakr Y., Dubois M.J., De Backer D., et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32:1825-1831.
14. Lam C., Tyml K., Martin C., et al. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994, 94:2077-2083.
15. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28:2729-2732.
16. Trzeciak S., Rivers E.P. Clinical manifestations of disordered microcirculatory perfusion in severe sepsis. Crit Care 2005, 9(Suppl 4):S20-S26.
17. Spronk P.E., Zandstra D.F., Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 2004, 8:462-468.
18. Bateman R.M., Sharpe M.D., Ellis C.G. Bench-to-bedside review: microvascular dysfunction in sepsis-hemodynamics, oxygen transport, and nitric oxide. Crit Care 2003, 7:359-373.
19. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003, 101:3765-3777.
20. Ince C., Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999, 27:1369-1377.
21. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
22. Rivers E.P., Kruse J.A., Jacobsen G., et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007, 35:2016-2024.
23. Marchick M.R., Kline J.A., Jones A.E. The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Med 2009, 35:1261-1264.
24. Weil M.H., Afifi A.A. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970, 41:989-1001.
25. Younger J.G., Falk J.L., Rothrock S.G. Relationship between arterial and peripheral venous lactate levels. Acad Emerg Med 1996, 3:730-734.
26. Jones A.E., Leonard M.M., Hernandez-Nino J., et al. Determination of the effect of in vitro time, temperature, and tourniquet use on whole blood venous point-of-care lactate concentrations. Acad Emerg Med 2007, 14:587-591.
27. Falk J.L., Rackow E.C., Leavy J., et al. Delayed lactate clearance in patients surviving circulatory shock. Acute Care 1985, 11:212-215.
28. Silverman H.J. Lack of a relationship between induced changes in oxygen consumption and changes in lactate levels. Chest 1991, 100:1012-1015.
29. Friedman G., Berlot G., Kahn R.J., et al. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995, 23:1184-1192.
30. Abramson D., Scalea T.M., Hitchcock R., et al. Lactate clearance and survival following injury. J Trauma 1993, 35:584-589.
31. Henning R.J., Weil M.H., Weiner F. Blood lactate as a prognostic indicator of survival in patients with acute myocardial infarction. Circ Shock 1982, 9:307-315.
32. Bakker J., Coffernils M., Leon M., et al. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1991, 99:956-962.
33. Bakker J., Gris P., Coffernils M., et al. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996, 171:221-226.
34. Rashkin M.C., Bosken C., Baughman R.P. Oxygen delivery in critically ill patients. Relationship to blood lactate and survival. Chest 1985, 87:580-584.
35. Vincent J.-L., Dufaye P., Berre J., et al. Serial lactate determinations during circulatory shock. Crit Care Med 1983, 11:449-451.
36. Parker M.M., Shelhamer J.H., Natanson C., et al. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of progress. Crit Care Med 1987, 15:923-929.
37. Bernardin G., Pradler C., Tiger F., et al. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med 1996, 22:17-25.
38. Boyd O., Grounds R.M., Bennett E.D. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993, 270:2699-2707.
39. Donnino M.W., Nguyen B., Jacobsen G., et al. Cryptic septic shock: a sub-analysis of early, goal-directed therapy. Chest 2003, 124:90S.
40. Howell M.D., Donnino M., Clardy P., et al. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 2007, 33:1892-1899.
41. Mikkelsen M., Miltiades A., Gaieski D., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009, 37:1670-1677.
42. Nguyen H.B., Rivers E.P., Knoblich B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004, 32:1637-1642.
43. Arnold R.C., Shapiro N.I., Jones A.E., et al. Multi-center study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 2009, 34:36-40.
44. Jones A.E., Shapiro N.I., Trzeciak S., et al. Lactate clearance versus central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010, 303:739-746.
45. Gattinoni L., Brazzi L., Pelosi P., et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995, 333:1025-1032.
46. Rhodes A., Cusack R.J., Newman P.J., et al. A randomized, controlled trial of the pulmonary artery catheter in critically ill patients. Intensive Care Med 2002, 28:256-264. [see comment].
47. Richard C., Warszawski J., Anguel N., et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003, 290:2713-2720.
48. Harvey S., Harrison D.A., Singer M., et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomized controlled trial. Lancet 2005, 366:472-477.
49. Binanay C., Califf R.M., Hasselblad V., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005, 294:1625-1633.
50. Ardsnet, Wheeler A.P., Bernard G.R., et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006, 354:2213-2224.
51. Rivers E.P., Ander D.S., Powell D. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001, 7:204-211.
52. Scheinman M.M., Brown M.A., Rapaport E. Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients. Circulation 1969, 40:165-172.
53. Dueck M.H., Klimek M., Appenrodt S., et al. Trends but not individual values of central venous oxygen saturation agree with mixed venous oxygen saturation during varying hemodynamic conditions. Anesthesiology 2005, 103:249-257.
54. Bellomo R., Reade M.C., Warrillow S.J. The pursuit of a high central venous oxygen saturation in sepsis: growing concerns. Crit Care 2008, 12:130.
55. Creteur J., Carollo T., Soldati G., et al. The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007, 33:1549-1556.
56. Doerschug K.C., Delsing A.S., Schmidt G.A., et al. Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007, 293:H1065-H1071.
57. Skarda D.E., Mulier K.E., Myers D.E., et al. Dynamic near-infrared spectroscopy measurements in patients with severe sepsis. Shock 2007, 27:348-353.
58. Marik P.E. Sublingual capnography: a clinical validation study. Chest 2001, 120:923-927.
59. Creteur J., De B.D., Sakr Y., et al. Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 2006, 32:516-523.
60. Marik P.E., Bankov A. Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients. Crit Care Med 2003, 31:818-822.
61. Groner W., Winkelman J.W., Harris A.G., et al. Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 1999, 5:1209-1212.
62. Harris A.G., Sinitsina I., Messmer K. The Cytoscan Model E-II, a new reflectance microscope for intravital microscopy: comparison with the standard fluorescence method. J Vasc Res 2000, 37:469-476.
63. Mathura K.R., Vollebregt K.C., Boer K., et al. Comparison of OPS imaging and conventional capillary microscopy to study the human microcirculation. J Appl Phys 2001, 91:74-78.
64. Lehmann K.G., Gelman J.A., Weber M.A., et al. Comparative accuracy of three automated techniques in the noninvasive estimation of central blood pressure in men. Am J Cardiol 1998, 81:1004-1012.
65. Hayes M.A., Timmins A.C., Yau E.H., et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717-1722.
66. Jones A.E., Brown M.D., Trzeciak S., et al. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med 2008, 36:2734-2739.
67. Sevransky J.E., Nour S., Susia G.M., et al. Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature. Crit Care 2007, 11:R67.
68. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.